Vir Biotechnology, Inc. (NASDAQ:VIR) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Vir Biotechnology, Inc. (NASDAQ:VIR) came out with its quarterly results last week, and we wanted to see how the…